|
|
||||||||
Articles |
State University of New York, Stony Brook, Department of Oral Biology & Pathology, School of Dental Medicine, Health Sciences Center, Stony Brook 11794-8702, USA.
This paper is a summary of a panel discussion by the following panelists: L. Golub, J. te Koppele, G. Nieman, M. Nelson, R. Ashley, T. Sorsa, and S. Simon. The panel discussed the mechanisms by which the tetracyclines and their non-antimicrobial counterparts may provide therapeutic efficacy in a variety of chronic and acute diseases.
This article has been cited by other articles:
![]() |
C. Bouvet, S. Moreau, J. Blanchette, D. de Blois, and P. Moreau Sequential Activation of Matrix Metalloproteinase 9 and Transforming Growth Factor {beta} in Arterial Elastocalcinosis Arterioscler. Thromb. Vasc. Biol., May 1, 2008; 28(5): 856 - 862. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Liu, M. E. Ryan, H.-M. Lee, S. Simon, G. Tortora, C. Lauzon, M. K. Leung, and L. M. Golub A Chemically Modified Tetracycline (CMT-3) Is a New Antifungal Agent Antimicrob. Agents Chemother., May 1, 2002; 46(5): 1447 - 1454. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Du, Z. Ma, S. Lin, R. C. Dodel, F. Gao, K. R. Bales, L. C. Triarhou, E. Chernet, K. W. Perry, D. L. G. Nelson, et al. Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease PNAS, December 4, 2001; 98(25): 14669 - 14674. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| IADR Journals | Advances in Dental Research ® | Journal of Dental Research ® | Critical Reviews (1990-2004) |